Interestingly, hypoxia strongly increases PSMA expression in breast cancer cells, which might be addressed by fractionated [177Lu]Lu-PSMA therapy, with the first fraction targeting PSMA-expressing endothelial cells and, in this way, decreasing the oxygen supply. Here, FOLH1 is linked to breast cancer.